GLP-1 Market: Market Leaders Focus on Expanding Indications Beyond Diabetes Into Obesity and Cardiovascular Risk
Market Overview The GLP-1 Market has emerged as one of the most transformative segments within the global pharmaceutical and biotechnology landscape. GLP-1–based therapies, primarily used for diabetes management and obesity treatment, have reshaped how chronic metabolic disorders are addressed. These therapies mimic or enhance the action of glucagon-like peptide-1, a hormone...
0 Comentários 0 Compartilhamentos 62 Visualizações 0 Anterior
Patrocinado